- Guia, Miguel;
- Alpay, Nilgun;
- Gerardo, António;
- Madney, Yasmin;
- Abdelrahim, Mohamed;
- Saeed, Haitham;
- Harb, Hadeer;
- Gonçalves, Gil;
- Cabrita, Bruno;
- Alqahtani, Jaber;
- El-Khatib, Mohamad;
- Gómez-Ríos, Manuel;
- Fakharian, Atefeh;
- Ciobanu, Laura;
- Karim, Habib;
- Piervincenzi, Edoardo;
- Scharffenberg, Martin;
- Steiropoulos, Paschalis;
- LeMaster, William;
- Barjaktarevic, Igor;
- Wittenstein, Jakob;
- Diaz-Abad, Montserrat;
- Perren, Andreas;
- Nicolini, Antonello;
- Spadaro, Savino;
- Garuti, Giancarlo;
- Petroianni, Angelo;
- Esquinas, Antonio
High-flow nasal cannula oxygen therapy (HFNCOT) system consists of an air/oxygen supply system capable of delivering up to 100% humidified and heated oxygen at a flow rate of up to 80 L/min. The system includes a blender, active humidifier, single heated tube, and nasal cannula. HFNCOT has many physiological advantages compared with other standard oxygen therapies, such as anatomical dead space washout, more constant fraction of inspired oxygen, positive end-expiratory (PEEP) effect, supplement of adequate humidification and maintenance of muco-ciliary function. HFNCOT is mostly used for hypoxemic acute respiratory failure, although it also has other indications. HFNCOT is a common choice of physicians as its technology makes it more silent and comfortable. Though HFNCOT is used in many clinical settings, there is a lack of publications addressing devices and initial settings. We present a review on HFNCOT, with focus on device and application methodology.